Author pages are created from data sourced from our academic publisher partnerships and public sources.
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management
This paper is the first in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s disease… Expand
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
- G. Van Assche, A. Dignass, +32 authors J. Lindsay
- Journal of Crohn's & colitis
- 1 February 2010
Principal changes with respect to the 2004 ECCO guidelines Ileocolonoscopy is recommended within the first year after surgery where treatment decisions may be affected (Statement 8C). Thiopurines… Expand
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
BACKGROUND & AIMS Pouchitis is the major long-term complication after ileal pouch-anal anastomosis for ulcerative colitis. Most patients have relapsing disease, and no maintenance treatment study has… Expand
Modulation of human dendritic cell phenotype and function by probiotic bacteria
Background: “Probiotic” bacteria are effective in treating some inflammatory bowel diseases. However which bacteria confer benefit and mechanisms of action remain poorly defined. Dendritic cells,… Expand
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery,…
aDepartment of Pharmacology and Therapeutics, University of Porto; MedInUP, Centre for Drug Discovery and Innovative Medicines; Centro Hospitalar São João, Porto, Portugal bIBD Unit, DIMEC,… Expand
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
- R. Bibiloni, R. Fedorak, +5 authors R. Sartor
- The American Journal of Gastroenterology
- 1 July 2005
BACKGROUND AND AIMS:Intestinal bacteria have been implicated in the initiation and perpetuation of IBD; in contrast, “probiotic bacteria” have properties possibly effective in treating and preventing… Expand
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
Background: Ten to 15% of patients with pouchitis experience refractory or recurrent disease. The aim of this study was to evaluate the effectiveness of a single daily high dose probiotic preparation… Expand
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
This second section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn’s disease concerns treatment of active disease, maintenance of medically induced… Expand
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
- G. Van Assche, A. Dignass, +15 authors J. Lindsay
- Journal of Crohn's & colitis
- 1 February 2013
### 8.1 General Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the procedure of choice for most patients with ulcerative colitis (UC) requiring colectomy.1 Pouchitis is a non-specific… Expand
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.
- K. Lammers, P. Brigidi, +5 authors M. Campieri
- Medicine, Biology
- FEMS immunology and medical microbiology
- 1 September 2003
A new therapeutic approach for inflammatory bowel diseases is based on the administration of probiotic bacteria. Prokaryotic DNA contains unmethylated CpG motifs which can activate immune responses,… Expand